Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01814163

Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab — ANGIOMET  

Nonsquamous Nonsmall Cell Neoplasm of Lung Clinical Trial

Official title:
Observational Studies to Explore the Relation Between Angiogenic Markers and the Treatment Response With Carboplatin, Paclitaxel and Bevacizumab in First Line of Advanced Non-small-cell Lung Cancer With Non- Squamous Histology

Clinical Trial Summary

This is a pharmacogenomic study with carboplatin, paclitaxel and bevacizumab as first line therapy in patients with non-squamous advanced non-small cell lung cancer.

Clinical Trial Description

This is a observational study prospectively followed post-authorization. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01814163
Study type Observational
Source Spanish Lung Cancer Group
Contact
Status Completed
Phase N/A
Start date February 2011
Completion date February 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT03380871 - A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer Phase 1
Terminated NCT01373463 - Cisplatin and Pemetrexed With Radiation Followed by Lobectomy Phase 1
Completed NCT02679443 - Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy N/A
Not yet recruiting NCT05764928 - Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy Phase 1/Phase 2
Completed NCT02049060 - Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin Phase 1/Phase 2
Completed NCT02259582 - A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer Phase 2
Terminated NCT02831933 - Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma Phase 2
Terminated NCT02019979 - Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) Phase 2
Completed NCT01705184 - Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer. Phase 2
Not yet recruiting NCT02852798 - Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC N/A
Active, not recruiting NCT03846310 - A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer Phase 1